All Perspectives

International Trade & Investment Associate James Kim will be featured on a panel discussing the US manufacturing of key components needed to build a robust PV manufacturing ecosystem at the PV CellTech USA Conference on October 7, 2025.

ArentFox Schiff (AFS) recently advised GAME 7, a multi-platform sports and entertainment brand co-founded by New York Rangers legend and NHL Hall of Fame inductee Mark Messier, in a historic jersey patch sponsorship transaction with Madison Square Garden Sports Corp.

Headlines that Matter for Companies and Executives in Regulated Industries

AFS associate Xiang Qu presented at the New York City Bar Association on October 6.

The US Patent and Trademark Office (USPTO) has announced that it will permanently close the Rocky Mountain Regional Outreach Office in Denver, Colorado. This decision reflects the USPTO’s evolving approach to outreach, education, and examiner recruitment.

The time has never been better for the acute and post-acute healthcare sectors to develop strategic relationships.

On September 25, President Trump directed federal agencies to investigate and prosecute organizations and individuals that engage in “acts of political violence.”

The District of Columbia Court of Appeals recently issued a significant tax opinion dealing with whether parties to a real estate transaction could avoid transfer and recordation taxes on a long-term ground lease by characterizing it as a “retained” interest in a deed, rather than as a separate transfer.

The Rebalancing Expectations for Neighbors, Tenants, and Landlords (RENTAL) Act of 2025, as amended, brings sweeping reforms to District housing laws.

Partner D. Reed Freeman was quoted on how the massive amount of data artificial intelligence (AI) models need is potentially undermining one of privacy advocates’ key goals: data minimization.

ArentFox Schiff is pleased to announce that Partner and Executive Committee member Cristina Carvalho has been named to Washingtonian’s 2025 list of the “Most Powerful Women in Washington.”

Health Care Partner David Greenberg will present in a BARBRI CLE course titled “Overpayment Recoveries by Health Insurers: Bringing and Defending Claims, Evaluating Merits, Scope of Recovery” on October 1, 2025.

On September 29, the Bureau of Industry and Security (BIS) issued an interim final rule that significantly expands end user controls under the Export Administration Regulations (EAR) by extending restrictions to foreign entities owned, directly or indirectly, 50% or more by one or more parties on specified lists of proscribed companies, including the Entity List.

Consumer Products Industry Group co-leader, Lynn R. Fiorentino, presented at the 2025 American Conference Institute (ACI) Legal, Regulatory, and Compliance Forum on Cosmetics & Personal Care Products West Coast Edition.

Join International Trade & Investment Associate James Kim and Director of North American Manufacturing Birgit Matthiesen at the Canadian Transportation Equipment Association (CTEA)’s Annual Manufacturers’ Conference 2025.

On September 19, President Trump signed a Proclamation imposing an additional $100,000 fee on the US entry of certain H-1B employees, effective September 21.

A significant Patent Trial and Appeal Board (PTAB) decision authored by the US Patent and Trademark Office (USPTO) leadership, including the new USPTO Director John A. Squires, signals the importance of artificial intelligence (AI) innovations to the US economy and paves the way for patenting of AI and machine learning (ML) technologies.

Earlier this month, the US Department of Health and Human Services (HHS) and US Food and Drug Administration (FDA) announced a nationwide crackdown on direct-to-consumer (DTC) drug advertisements.

Headlines that Matter for Companies and Executives in Regulated Industries

The plaintiff, John Snyder, worked for a life insurance company from December 2006 to August 2016.

More than two years after the Integrity, Notification, and Fairness in Online Retail Marketplaces (INFORM) for Consumers Act took effect on June 27, 2023, the United States, on behalf of the Federal Trade Commission (FTC), brought the first enforcement action under the Act.

As the federal funding deadline of September 30, 2025, approaches, this alert highlights four possible scenarios and their potential implications.

Last month, the US Food and Drug Administration (FDA) announced that it would begin daily publication of adverse event data for drugs and biologics via the FDA Adverse Event Reporting System (FAERS).

Following nearly two years of litigation, Cigna Health and Life Insurance Company and the named plaintiffs in Hecht v. Cigna Health and Life Insurance Co., Case No. 1:24-cv-05926 (N.D. Ill.) have announced a class action settlement in principle.

On September 8, the US Department of Justice (DOJ) announced the withdrawal of dozens of pending rulemaking actions, including two related to the cannabis industry.